Capricorn Pharma is a specialty state-of-the-art pharmaceutical, technology driven company, engaged in innovation, development, commercialization and manufacturing of pharmaceutical products - Orally Disintegrating Dosage (ODD) forms, KORTABS - modified release dosage forms, and Micro-encapsulations with multiple processes.

CPI mission and strategy

  Increase Shareholders value - solid revenue base from development and manufacturing with good profit margins and sustainable growth.


  Develop  Human Capital leading to continuous innovation.


  Portfolio of value added Oral Drug Delivery systems- innovative multiple advanced technologies with broad applications across range of products in different therapeutic categories.


  Targeted products profile include improved compliance and easy administration, control of blood level of drugs, improve efficacy, reduce side effects and expand indications.


  Manufacture quality products that meet US FDA cGMP and other US and International regulatory requirements.


  Develop global business relationships and alliances for product development, licensing and product sale.